NP-120

ifenprodil · Algernon Pharmaceuticals

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for NP-120, covering 2021-12-03 to 2022-07-19. Get the full timeline:

Most recent: Clinical Trial Update: Efficacy, Safety and Tolerability of NP-120 on Idiopathic Pulmonary Fibrosis and Its Associated Cough [Phase 2]